Diabetes News

Among patients with diabetes, the teach-back method was associated with better interactions with health care providers, more engagement in shared decision-making and a greater likelihood of receiving lifestyle advice, data show.

Regardless of baseline eGFR, non-albuminuric diabetic kidney disease correlated with increased risks of hospitalization for heart failure and chronic kidney disease progression.

Every 5°C increase in daily mean temperature correlated with a 6% increase in hospitalization due to diabetes in Brazil between 2000 and 2015.

Diabetes self-management education and support interventions might help reduce health care costs and improve utilization, but evidence varies across studies, according to findings from a systematic review.

Health care costs remained high for Medicare beneficiaries with common chronic conditions for which brand-name medications without generic alternatives were recommended, according to findings published in JAMA Internal Medicine.

Sodium-glucose cotransporter 2 inhibitors are an effective class of drugs for improving morbidity and mortality in patients with established atherosclerotic CVD or cardiovascular risk factors, researchers reported.

Adults with autism spectrum disorder from underrepresented populations were more likely than white adults with ASD to have cooccurring conditions such as diabetes and hypertension, according to a recent analysis of Medicaid data.

An analysis of data showed patients with chronic kidney disease and type 2 diabetes who were or were not prescribed mineralocorticoid receptor antagonists saw reductions in major adverse kidney outcomes after taking dapagliflozin.

Mineralocorticoid receptor antagonists, particularly the most recently approved agent finerenone, should play a “central role” in the treatment of diabetic kidney disease and its related cardiovascular consequences, according to a speaker.

Emerging data suggest immunotherapies and novel peptides that target gut inflammation could serve as complementary agents to available diabetes drugs to more effectively target cardiometabolic diseases, according to a speaker.